TrypBodies™-Antibodies for Immuno-MRM (iMRM) - SISCAPA®

TrypBodies™-Antibodies for Immuno-MRM (iMRM) - SISCAPA®

The immunoaffinity enrichment of tryptic fragments for use in mass spec biomarker research (also known as SISCAPA) is rapidly gaining prominence.  NEP’s custom TrypBodies™, or anti-peptide antibodies against tryptic peptide fragments, can be used for tryptic fragment enrichment or purification, all of which may lead to superior analytical performance during the evaluation of protein expression and quantitation by MS. 

TrypBodies™- Monoclonal Antibodies

TrypBodies™-Polyclonal Antibodies

TrypBodies™- Exclusive to NEP, SISCAPA® Licensed Polyclonal Antibodies including SISCAPA® License

• Custom monoclonal and polyclonal anti-tryptic peptide antibodies

• Experience in production of peptides and antibodies since 1998

• You own the antibody and the antibody IP

• iMRM specific sequence design consultation – these are not your normal anti-peptide antibodies

• Peptide synthesis with the highest purity and quality in the industry

• Specialized coupling and blocking strategies for optimal immunization

• Animal facilities are AAALAC accredited, OLAW assured and USDA licensed

• Post-immunization ELISA follow up and detailed consultation

• Specialized affinity purification protocols for pAbs for optimal performance

• Flexible Ab protocols and additional characterization available

The final result is specific antibodies that are functionally optimized for iMRM. 

Coupled with our NEPTune™ services for custom heavy peptide synthesis, and TrypKits™ for custom kit manufacture, TrypBodies™ are the solution to your needs for custom iMRM reagents. 

get custom monoclonal antibodies quote

Or contact us at  As always do not hesitate to call us at 888-343-5974.

Also ask about NEP’s TrypKits™, TrypTides™ and TrypRaws™


"THANKS AGAIN for all the intellectual support that NEP has provided to us over the last year. My colleagues have been overwhelmingly impressed with the quality of service and level of thought that you have put into researching and thinking about our particular peptide and antibody production needs. The level of scholarship went well beyond what we expected from any peptide and antibody company, and was crucial in shaping our decisions. It has truly been a pleasure corresponding with you."
Cliff N. PhD - Lawrence Berkeley National Laboratory